EichorEICHOR
Location: Bod Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Bod

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Pre
Phase N/A · Nantes University Hospital · NCT05856565
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380
Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · Fondation Hôpital Saint-Joseph · NCT05674994
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853
Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
Phase 2 · Institut Curie · NCT07193394
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Princess Maxima Center for Pediatric Oncology · NCT05327894
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Merck Sharp & Dohme LLC · NCT07266831
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762
Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma
Phase N/A · University Hospital, Bordeaux · NCT06430424
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Boehringer Ingelheim · NCT07355296
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Phase 1/Phase 2 · Novartis Pharmaceuticals · NCT06704269
French Colorectal ESD Cohort in Experts Centers
Phase N/A · University Hospital, Limoges · NCT04592003
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Takeda · NCT07108283
A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
Phase 2 · AstraZeneca · NCT07571746
Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Poitiers University Hospital · NCT05686850
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · CellCentric Ltd. · NCT04068597
Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278
Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections
Phase 3 · Centre Hospitalier Universitaire de Nice · NCT05902221
TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Phase N/A · NovoCure Ltd. · NCT06924099
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Merck Sharp & Dohme LLC · NCT07216703
Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
Phase 1/Phase 2 · Centre Leon Berard · NCT07243470
Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Hospices Civils de Lyon · NCT05444712
Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · The Lymphoma Academic Research Organisation · NCT06006117
Assessment and Follow-up of Surgical Treatment of Hemivertebra in Children
Phase N/A · University Hospital, Tours · NCT03772119
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Pharmaceuticals · NCT06581198
In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.
Phase 3 · University Hospital, Bordeaux · NCT03998852
Interest of Sperm Insemination at 42 Hours Post hCG Compared to 36h in Intrauterine Insemination
NA · University Hospital, Toulouse · NCT06804538
Look up another city
Look up another condition